Search results for: Pricing and Reimbursement
Filter search results
OHE’s 60th Anniversary Party – Celebrating Our Achievements and Looking Forward
21 June 2022
…4 Hamilton Place, an Edwardian Mansion in the heart of Mayfair, London. About 140 attendants were served nibbles and drinks on the terrace with views over Hyde Park and listened…
Health Care Services and the Single European Market
1 September 2008
…health systems are compatible; the potential impact of increased competition on efficiency, quality and access to health services and the effect of relying on patient choice to promote competition; and…
Productivity Costs: Principles and Practice in Economic Evaluation
11 January 2000
…are the human capital approach, the friction cost approach and the approach recommended by the US Panel on Cost-Effectiveness in Health and Medicine. The friction cost approach responds to concerns…
Biosimilar Competition: Lessons from Europe and Prospects for the US
1 October 2014
…evolved since 2009 in France, Germany, Italy, Sweden and the UK. The author highlights two key results. Firstly, the market experience varies greatly across product classes and countries – mainly…
International Cost-Effectiveness Thresholds and Modifiers for HTA Decision Making
5 January 2020
…these countries, this review examines whether an explicit or implicit CET is used, and the additional considerations (here termed ‘modifiers’) that are incorporated when funding and reimbursement decisions are made….
The BRAVE Initiative: The BRAVE Narrative for Broad Recognition of Value in Vaccines Engagement
1 September 2020
…full benefits, referred to as their ‘broader value’, can lead to undervaluing vaccines. This, in turn, may lead to suboptimal vaccine development, recommendation, and reimbursement decisions. To address this issue,…
Navigating the Landscape of Digital Health – United Kingdom
16 December 2022
…value assessment and reimbursement, and efforts to increase the digital literacy of the general population and the health workforce. We provide lessons learned that may be of value to decision-makers…
OHE at ISPOR 2024
5 May 2024, 12:00am
…the Dimensions of Sustainable Global Biosimilars Markets Mireia Jofre-Bonet 06 May 2024 10:30 EDT Poster Session Value Assessment and Reimbursement of Early Treatment for Prevention in Chronic Progressive Diseases: Are…
Using Target Product Profiles (TPPs) to improve diagnostic testing for cancer
10 June 2024
…experts, research and innovation funders, innovators in research institutes and industry, regulators, health technology assessment expertise, policymakers and payers, and the patient voice. TPP development has two key stages: inception…